Cancer biotherapy with interferon, interleukin-2 and tumor-derived activated cells (TDAC)

Autor:	R K, Oldham, W M, Lewko, R W, Good, E, Sharp
Rok vydání:	1994
Předmět:	Clinical Trials as Topic Lymphocytes Tumor-Infiltrating Lymphocyte Transfusion Neoplasms Humans Interleukin-2 Female Interferons Killer Cells Lymphokine-Activated Lymphocyte Activation Transplantation Autologous Cells Cultured Recombinant Proteins
Zdroj:	In vivo (Athens, Greece). 8(5)
ISSN:	0258-851X
Popis:	Interleukin-2 (Il-2) allows for the therapeutic augmentation of immunity in vivo and/or in vitro. In extensive studies in nearly 1000 patients with advanced cancer, we have demonstrated that Il-2 by continuous infusion, with cellular therapy (LAK or TDAC), is feasible, cost effective and useful in selected patients with melanoma and kidney cancer. Studies in patients with other tumor types are underway.
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=pmid________::9161bff3c6e8ed5684b0960ab0d2d6eb https://pubmed.ncbi.nlm.nih.gov/7537108 Zobrazit plný text záznamu